Iron transport mechanisms in reticulocytes and mature erythrocytes.
The mechanism of iron transport into erythroid cells was investigated using rabbit reticulocytes and mature erythrocytes incubated with 59Fe-labelled Fe(II) in isotonic sucrose or in solutions in which the sucrose was replaced with varying amounts of isotonic NaCl or KCl. Iron uptake was inhibited at all concentrations of NaCl, in a concentration-dependent manner, but with KCl inhibition occurred only at concentrations up to 10 mM. Higher KCl concentrations stimulated iron uptake to the cytosol of the cells, but inhibited its incorporation into heme. This effect became more marked as the iron concentration was raised. It was found that KCl inhibits iron incorporation into heme and stimulates iron uptake by mature erythrocytes, as well as by reticulocytes. It is concluded that erythroid cells can take up nontransferrin-bound Fe(II) by two mechanisms. One is a high-affinity mechanism that is limited to reticulocytes, saturates at a low iron concentration, and is inhibited by metabolic inhibitors. The other is a low-affinity process that is found in both reticulocytes and erythrocytes, becomes more prominent at higher iron concentrations, and is stimulated by KCl, as well as RbCl, LiCl, CsCl, and choline Cl. The KCl stimulation is inhibited by amiloride, but not by metabolic inhibitors, and its operation is not dependent on changes in cell volume or membrane potential, but it does require the presence of a permeant extracellular anion. Iron uptake by this process appears to occur by facilitated transport and is possibly associated with exchange of Na+. A further aspect of this study was a comparison of iron uptake by reticulocytes from Fe(II)-sucrose and Fe(II)-ascorbate using a variety of incubation conditions. No major differences were observed.
Hodgson
L L
LL
Department of Physiology, University of Western Australia, Nedlands.
Quail
E A
EA
Morgan
E H
EH
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D001205:Ascorbic Acid; D001692:Biological Transport / Q000187:drug effects; D003600:Cytosol / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism*; D005296:Ferrous Compounds / Q000097:blood*; D006418:Heme / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D008564:Membrane Potentials; D009994:Osmolar Concentration; D011189:Potassium Chloride / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012156:Reticulocytes / Q000378:metabolism*; D012965:Sodium Chloride / Q000494:pharmacology; D013395:Sucrose; D014168:Transferrin / Q000378:metabolism
D005296:Ferrous Compounds; D014168:Transferrin; D006418:Heme; D012965:Sodium Chloride; D013395:Sucrose; D011189:Potassium Chloride; D000584:Amiloride; D001205:Ascorbic Acid